Grifols and Shanghai RAAS obtain authorization for their strategic alliance in China
(WorldNews Spain)

Grifols and Shanghai RAAS obtain authorization for their strategic alliance in China The operation is expected to close before the end of 2019, after the necessary approvals have been received from the regulatory authorities in the United States and the People`s Republic of China Grifols will control a 26.2% stake in Shanghai RAAS (economic and voting rights) in exchange for a non-majority share (45% economics rights and 40% voting rights) in Grifols Diagnostic Solutions (GDS), a wholly owned Grifols subsidiary This transaction is the first share swap made in China with shares of a foreign company (GDS) and a non-state-controlled Chinese listed company This alliance is an important step...